Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.
Globisch D, Münzel M, Müller M, Michalakis S, Wagner M, Koch S, Brückl T, Biel M, Carell T. · 2010
Read Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. by Globisch D, Münzel M, Müller M, Michalakis S, Wagner M, Koch S, Brückl T, Biel M, Carell T. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3009720.txt.
Introduction
Globisch and co-authors measured a sixth DNA base, hydroxymethylcytosine, across mouse tissues in a 2010 study. They also hunted for further bases. Such bases would prove an active removal pathway for methylation marks. The new base forms from the classic methyl mark, and its job was unknown.
Using an ultra-sensitive isotope method, they found the base in every tissue and cell type, richest in brain nerve cells. The expected follow-on bases of a stepwise removal chain were essentially absent, arguing against that demethylation route. The base looks more like a stable feature of nerve cells than a passing step.
Catalog record
| CREATOR | Globisch D, Münzel M, Müller M, Michalakis S, Wagner M, Koch S, Brückl T, Biel M, Carell T. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates By Daniel Globisch, Martin Münzel, Markus Müller, Stylianos Michalakis, Mirko Wagner, Susanne Koch, Tobias Brückl, Martin Biel, Thomas Carell, Anna Kristina Croft Published in: PLoS ONE DOI: 10.1371/journal.pone.0015367 ABSTRACT Abstract 5–Hydroxymethylcytosine (hmC) was recently detected as the sixth base in mammalian tissue at so far controversial levels. The function of the modified base is currently unknown, but it is certain that the base is generated from 5-methylcytosine (mC). This fuels the hypothesis that it represents an intermediate of an active demethylation process, which could involve further oxidation of the hydroxymethyl group to a formyl or carboxyl group followed by either deformylation or decarboxylation. Here, we use an ultra-sensitive and accurate isotope based LC-MS method to precisely determine the levels of hmC in various mouse tissues and we searched for 5–formylcytosine (fC), 5-carboxylcytosine (caC), and 5–hydroxymethyluracil (hmU) as putative active demethylation intermediates. Our data suggest that an active oxidative mC demethylation pathway is unlikely to occur. Additionally, we show using HPLC-MS analysis and immunohistochemistry that hmC is present in all tissues and cell types with highest concentrations in neuronal cells of the CNS. INTRODUCTION In 2009 it was discovered that the genetic material contains aside from the nucleobases A, C, G, T, and 5-methylcytosine (mC) the additional sixth base 5-hydroxymethylcytosine (hmC) [1], [2]. Whereas it is well established that mC is a crucial epigenetic marker [3], the function of the sixth base hmC is currently unknown, but it is speculated that it is involved in epigenetic regulation events or in active demethylation processes [4], [5], [6], [7], [8]. It was discovered that the base is generated from mC as precursor via oxidation (hydroxylation) by members of the TET enzyme family [2], [9]. These TET enzymes are Fe(II)-dependent α-oxoglutarate dioxygenases, which utilize molecular oxygen to hydroxylate alkyl groups to hydroxymethyl functionalities via a radical based mechanism [10]. It is currently hypothesized that hmC could be a base involved in epigenetic modulation of gene activity. The fact that hmC was also discovered in embryonic stem cells (ES cells) and seems to play an important role in ES cells self-renewal supports this hypothesis [9]. The base was originally detected in several tissues with the highest levels in mammalian brain. In brain tissues, between 0.4% and 0.7% of all dC bases were found to be converted into hmC [1]. These values are in good agreement with a recent, more detailed LC-MS study developed in our laboratory [11]. The amount of hmC in other tissues was initially found to be small with levels up to 0.1% but more precise quantification could not be obtained due to the sensitivity limitations associated with the early detection method. In an alternative attempt to achieve better information about the hmC content, an enzymatic approach was taken in which UDP-[3H]glucose was used as a marker, which was transferred onto hmC with the help of a specific glucosyltransferase. This assay provided hmC values far higher than those reported earlier [12]. hmC could in principle directly modulate the binding of proteins to DNA also during epigenetic regulation processes. For example it was shown that methyl-CpG binding protein 2 (MeCP2) no longer binds to the corresponding sequences when mCs were converted to hmCs in CpG sequences [13]. Alternatively, it could function as an intermediate in active oxidative demethylation ( Figure 1 ) [14]. Oxidation of the hydroxymethyl group to a formyl group would yield 5-formylcytosine (fC) which could expel formic acid and react to C. Another possibility would be further oxidation of hmC to 5-carboxylcytosine (caC) which possesses a carboxyl group and would enable quick decarboxylation to regenerate dC ( Figure 1 ). Nature's most proficient enzyme orotate decarboxylase catalyzes a similar reaction in which orotate is decarboxylated to uridine [15]. Similar oxidation and decarboxylation reactions are known for thymine in the pyrimidine salvage pathway of certain eukaryotes [16], [17], [18]. Alternatively, hmC or its deamination product hmU could be substrates of specialized DNA glycosylases [6], [19], [20], [21]. Recent observations that epigenetic reprogramming is associated with the activation of base excision repair (BER) pathways support this hypothesis [22], [23]. During preparation of this manuscript a review was published, which independently postulated these two putative pathways for active DNA demethylation [24]. [Figure: Putative demethylation pathways.Depiction of the known cytosine modifications mC and hmC and of the putative oxidative “demethylation” intermediates fC and caC. The base excision repair (BER) pathway is a second possible demethylation pathway via the intermediate hmU.] RESULTS In order to test the idea that hmC is an intermediate of such an oxidative demethylation pathway and to shine light on the distribution of hmC in mammalian tissues we applied an isotope based HPLC-MS method to quantify hmC and to detect the presence of fC, caC, and hmU in various tissues. Mass spectrometry is a highly sensitive detection method that is, however, not quantitative. (In certain cases mass spectrometry was used for quantification of nucleosides [25]). Using stable isotope-labeled reference compounds, which have the same chromatographic and ionization properties but different molecular weights, turns MS into a quantitative method [11], [26], [27], [28]. By comparing the integrals of the individual mass signals of the natural compound (amount to be determined) and labeled compound (known amount) and subsequent application of calibration curves (Figure S1) very precise quantification of the natural compound is achieved. Synthesis of modified cytosine derivatives The syntheses of the putative intermediates fC, caC, and hmU are depicted in Figure 2 . Starting point was dC, which was first iodinated at position 5 and subsequently TBS protected to yield 1 [29]. A Pd-catalyzed carbonylation with Bu3SnH gave formylated compound 2. This reaction proceeded in excellent yield even in the presence of the unprotected amine at position 4. Deprotection of 2 with HF in pyridine generated fC. hmC was easily obtained after reduction of 2 and subsequent deprotection of the TBS groups. Here, addition of a Lewis acid [30] was essential, because simple reduction using NaBH4 resulted mainly in decomposition of the starting material, presumably because the hydride added to the position 6 of intermediate 2. For the synthesis of the isotope-labeled standard [D2]-hmC for mass spectrometric analyses Bu3SnD and NaBD4 were used in the formylation and reduction reactions, respectively (for details refer to the Text S1 and for a protective group free synthesis see Figure S2). For the synthesis of caC we converted iodine 1 to a TMS-ethanol-ester in a Pd-catalyzed reaction to yield compound 3 and subsequently cleaved the protective groups. Fully protected 4 was synthesized according to a literature procedure and converted to hmU with HF·pyridine [11]. [Figure: Synthesis of [D2]-hmC and the putative intermediates fC, caC, and hmU.a) CO, PPh3, Pd2(dba)3·CHCl3, Bu3SnH, 97%, with Bu3SnD 49%, b) HF pyridine, 75%, c) NaBD4, CeCl3·7H2O, 21%, d) TBAF, 51%, e) CO, TMS-Et-OH, DIPEA, Pd2Cl2(MeCN)2, 52%, f) TBAF, 69%, g) Reference [11] h) HF·pyridine, 70%. All reactions could also be carried out in a protective group free manner but resulted in reduced yields and tedious workups (see Figure S2 for details).] HPLC-MS Quantification of hmC and mC in Mammalian Tissue Using the LC-MS method, we quantified the levels of hmC and mC in parallel using the isotope-labeled derivative [D2]-hmC. This reference compound